GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,763 | 3,604 | 3,906 | 3,091 | 3,168 |
| Operating Income | -3,763 | -3,604 | -3,906 | -3,091 | -3,168 |
| Other Income | -12 | 193 | 196 | 825 | 206 |
| Pre-tax Income | -3,775 | -3,411 | -3,710 | -2,266 | -2,962 |
| Net Income Continuous | -3,775 | -3,411 | -3,710 | -2,266 | -2,962 |
| Net Income | $-3,775 | $-3,411 | $-3,710 | $-2,266 | $-2,962 |
| EPS Basic Total Ops | -1.60 | -1.53 | -2.17 | -1.64 | -2.17 |
| EPS Basic Continuous Ops | -1.60 | -1.53 | -2.17 | -1.64 | -2.17 |
| EPS Diluted Total Ops | -1.60 | -1.53 | -2.17 | -1.64 | -2.17 |
| EPS Diluted Continuous Ops | -1.60 | -1.53 | -2.17 | -1.64 | -2.17 |
| EPS Diluted Before Non-Recurring Items | -1.66 | -1.53 | -2.24 | N/A | N/A |
| EBITDA(a) | $-3,763 | $-3,604 | $-3,906 | $-3,091 | $-3,168 |